Abstract
In Ethiopia cervical carcinoma is the most frequent cancer in women. HPV infection is a prerequisite for this disease. However, to date there have been no data on human papilloma virus (HPV) prevalence in Ethiopia. Outpatients attending Attat hospital in rural Ethiopia were examined for the presence of HPV DNA using the Digene HPV test. 15.9% of patients were found to be HPV positive. The proportion of HPV high risk types was 13.2% [age-standardised rates: HPV: 14.4% (95% CI: 8.5–20.2); HPV high risk: 11.6% (95% CI: 6.3–16.9)]. Compared to other countries HPV prevalence is high, especially of high risk types. Until vaccination programmes take effect, screening programmes should not be based on HPV testing alone as this will lead to significant overtreatment of healthy women.
Article PDF
Avoid common mistakes on your manuscript.
References
GEKID (2006) Krebs in Deutschland. Häufigkeiten und Trends. Saarbrücken: GEKID, Robert Koch Institut
Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. (2006) HPV-mediated cervical carcinogenesis: Concepts and clinical implications J Pathol 208(2):152–164
Munoz N, Bosch FX, de Sanjose S, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518–527
Schiffman M, Castle PE. (2005) The promise of global cervical-cancer prevention N Engl J Med 353(20):2101–2104
Clifford GM, Gallus S, Herrero R, et al. (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis Lancet 366(9490):991–998
Terry G, Ho L, Londesborough P, Cuzick J, Mielzynska-Lohnas I, Lorincz A. (2001) Detection of high-risk HPV types by the hybrid capture 2 test J Med Virol 65(1):155–162
Doll R, Payne P, Waterhouse JBS-Vf, UICC. Cancer Incidence in Five Continents: A Technical Report. Berlin: Springer Verlag, 1966
Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. (2005) Cost-effectiveness of cervical-cancer screening in five developing countries N Engl J Med 353(20):2158–2168
Kelly J, Fekadu S, Lancashire RJ, Poovan P, Redito A. (1998) A follow-up of repair of ruptured uterus in Ethiopia J Obstet Gynaecol 18(1):50–52
Denny L, Kuhn L, Pollack A, Wainwright H, Wright TC Jr (2000) Evaluation of alternative methods of cervical cancer screening for resource-poor settings Cancer 89(4):826–833
El-Shalakany A, Hassan SS, Ammar E, Ibrahim MA, Salam MA, Farid M. (2004) Direct visual inspection of the cervix for the detection of premalignant lesions J Low Genit Tract Dis 8(1):16–20
Basu PS, Sankaranarayanan R, Mandal R, et al. (2003) Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India Int J Gynecol Cancer 13(5):626–632
Harper DM, Franco EL, Wheeler C, et al. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial Lancet 364(9447):1757–1765
Villa LL, Costa RL, Petta CA, et al. (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet Oncol 6(5):271–278
Acknowledgements
To Hartmut Götte PhD, Digene Corp., Germany, for HPV diagnostic test kits, Birgit Konert and Magdalena Marciniak for expert technical assistance, and Jürgen Wellmann for statistical advice.
Author information
Authors and Affiliations
Corresponding author
Additional information
Sr. Rita Schiffer, M.D., Member of the Medical Mission Sisters and Medical Director, Attat Hospital.
Rights and permissions
About this article
Cite this article
Ruland, R., Prugger, C., Schiffer, R. et al. Prevalence of human papilloma virus infection in women in rural Ethiopia. Eur J Epidemiol 21, 727–729 (2006). https://doi.org/10.1007/s10654-006-9055-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-006-9055-4